MedTrace Logo

The Effectiveness of Pilates in Women With Lumbar Disc Herniation

NCT07261020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-29

No results posted yet for this study

Summary

The aim of the study was to compare the effects of reformer pilates and mat exercise on pain, quality of life and kinesiophobia in female patients with lumbar disc herniation.

Conditions

  • Disc Herniation
  • Kinesiophobia
  • Low Back Pain

Interventions

OTHER

mat pilates

The mat pilates group was given an exercise program consisting of 16 sessions, 2 days a week, for 8 weeks. All exercises were performed as one set of 15 repetitions for the first 2 weeks, 15 repetitions for the 3rd and 4th weeks, and 15 repetitions for the 5th and 6th weeks, with 20 repetitions for the final 2 weeks. Exercise intensity (number of repetitions and level of movement) was gradually increased. Priority was given to core muscles when selecting exercises. The aim was to work the transversus abdominis, multifidus, and gluteus muscles both eccentrically and concentrically, while maintaining spinal stabilization and fostering awareness during movement. The exercise protocol was performed twice a week for 8 weeks, with each session lasting 45 minutes.

OTHER

reformer pilates

The Reformer Pilates group was assigned an exercise program consisting of 16 sessions, 2 days a week, for 8 weeks. All exercises were performed as one set of 15 repetitions for the first 2 weeks, 15 repetitions for the 3rd and 4th weeks, and 20 repetitions for the 5th and 6th weeks. Exercise intensity (number of repetitions and level of movement) was gradually increased. Priority was given to core muscles when selecting exercises. The aim was to work the transversus abdominis, multifidus, and gluteus muscles both eccentrically and concentrically, while maintaining spinal stabilization and fostering awareness during movement. The exercise protocol consisted of 45-minute sessions, 2 days a week, for 8 weeks.

Sponsors & Collaborators

  • Uskudar University

    lead OTHER

Principal Investigators

  • Ayça Bilgi · Uskudar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-05
Primary Completion
2024-03-15
Completion
2024-05-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07261020 on ClinicalTrials.gov